BIOMEDRO GmbH is committed to basic medical research, the development of diagnostic test systems, and the carrying out of clinical studies investigating innovative treatment and diagnostic strategies in rheumatic autoimmune diseases. The medical research has a predominant focus on biomarker discovery using sophisticated proteomics approaches such as two-dimensional gel electrophoresis. BIOMEDRO DIAGNOSTICS develops ELISA tests using individual, highly purified recombinant antigens – resulting in hits that are very specific.